OTCMKTS:AMAR Amarillo Biosciences (AMAR) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free AMAR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.60▼$0.6052-Week Range N/AVolume6,100 shsAverage Volume18,253 shsMarket Capitalization$25.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Amarillo Biosciences alerts: Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Amarillo Biosciences Stock (OTCMKTS:AMAR)Amarillo Biosciences, Inc., a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases. The Medical division focuses on medical devices and developing technology to treat metabolism related diseases, such as Type 1 and Type 2 diabetes. The Consumer division provides a range of nutraceutical and food supplement products that utilize a liposomal delivery system. It owns four issued patents related to the low-dose oral delivery of interferon; one patent is for a product promoting oral health; and three patents are associated with treatment of metabolic disorders. The company was incorporated in 1984 and is based in Amarillo, Texas.Read More Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him AMAR Stock News HeadlinesApril 3, 2024 | msn.comTexas Rising Stars award honors two Amarillo lawyersMarch 31, 2024 | msn.comRising Stars attorneys, Midland wildfire donations among this week's business newsApril 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.January 26, 2024 | yahoo.comOvernight shooting incidents in Amarillo leave 1 dead, 1 critically injuredDecember 20, 2023 | investing.comGufic Biosciences Ltd (GUFI)September 6, 2023 | forbes.comBest Internet Providers In Amarillo, Texas Of 2023August 29, 2023 | usnews.comOjo Amarillo ElementaryMay 21, 2023 | cnet.comBest Internet Providers in Amarillo, TexasApril 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 18, 2023 | cbsnews.comFederal judge in Amarillo to rule on potential abortion pill ban 'as soon as possible'March 17, 2023 | cbsnews.comAbortion pill challenge goes before judge in AmarilloMarch 10, 2023 | marketwatch.comThrombocytopenia Management Market Size 2023 Research Report by Raw Materials Analysis and Forecast till 2027February 28, 2023 | msn.comPotter County Commissioners’ Court rescinds Willow Creek land donation to Homeless HeroesFebruary 9, 2023 | msn.comHomeless Heroes holds meeting with Willow Creek residents to address concerns, questionsFebruary 1, 2023 | finance.yahoo.comPyramid Biosciences to Present at the B. Riley Securities Third Annual Oncology ConferenceJanuary 30, 2023 | marketwatch.comInterferon Alpha-2a Biosimilar Market 2023 Statistics, Share Price, Growth Prospects, Industry Trends till 2028January 27, 2023 | news.yahoo.comAmarillo singer Tony Christie talks about living with dementiaJanuary 23, 2023 | finanznachrichten.deAinos, Inc.: Ainos and Tah-An Sign MoU to Explore Manufacture of VELDONA Animal Investigational New DrugJanuary 23, 2023 | news.yahoo.comRemains identified as Amarillo man missing since JuneJanuary 21, 2023 | news.yahoo.comAmarillo man sentenced in federal court for transporting woman for prostitutionJanuary 17, 2023 | news.yahoo.comAmarillo health leader speaks about new COVID variant, heart issues and vaccine effectsJanuary 9, 2023 | thestreet.comAmarillo Biosciences Inc NewsDecember 31, 2022 | finance.yahoo.comJourney Biosciences launches NaviDKD™ for people with diabetes to predict long-term kidney complicationsSeptember 22, 2022 | newsweek.comAmarillo Shooting as Officer Gunned Down in 'Pure Chaos' at Tri-State FairSeptember 22, 2022 | dallasnews.comGunman shoots 3 at Amarillo fair before being shot by deputiesSeptember 21, 2022 | msn.comU.N. secretary-general warns world leaders: 'We cannot go on like this'August 16, 2022 | seekingalpha.comAmarillo Biosciences GAAP EPS of -$0.01, revenue of $636.62MSee More Headlines Receive AMAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amarillo Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2018Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:AMAR CUSIPN/A CIK1014763 Webwww.amarbio.com Phone806-376-1741FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,450,000.00 Net Margins-41,453.98% Pretax MarginN/A Return on EquityN/A Return on Assets-574.29% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.07 Sales & Book Value Annual Sales$20,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / BookN/AMiscellaneous Outstanding Shares42,066,000Free FloatN/AMarket Cap$25.24 million OptionableNot Optionable Beta-0.06 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Stephen T. Chen (Age 71)Chairman, CEO, Pres, CFO & COO Comp: $340.98kMr. Bernard Cohen (Age 68)VP of Admin. Comp: $83.08kMr. John Junyong Lee Esq.Chief Legal Counsel & Sec.Key CompetitorsUnity BiotechnologyNASDAQ:UBXSensei BiotherapeuticsNASDAQ:SNSEAcurx PharmaceuticalsNASDAQ:ACXPAileron TherapeuticsNASDAQ:ALRNEyenoviaNASDAQ:EYENView All Competitors AMAR Stock Analysis - Frequently Asked Questions How were Amarillo Biosciences' earnings last quarter? Amarillo Biosciences, Inc. (OTCMKTS:AMAR) released its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.02 million for the quarter. What other stocks do shareholders of Amarillo Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Amarillo Biosciences investors own include Fulcrum Therapeutics (FULC), Cerecor (CERC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Spectrum Pharmaceuticals (SPPI), Sorrento Therapeutics (SRNE), Vistagen Therapeutics (VTGN), vTv Therapeutics (VTVT), Abeona Therapeutics (ABEO) and Bausch Health Companies (BHC). How do I buy shares of Amarillo Biosciences? Shares of AMAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AMAR) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeHow to camouflage a factory of 53,000 workersStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amarillo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
